State Specialty Directory
Rheumatology in GA
Federal CMS data for 114 rheumatology providers across GA. Includes Medicare utilization, Open Payments industry funding, and PECOS enrollment status.
114
Providers
Median industry payments
$7,300
114
Rheumatology Providers
in GA
$7,300
Median Industry Payments
per provider (2018–2024)
1,922
Median Medicare Services
fee-for-service claims
How to read this directory: Providers are listed by Medicare service volume, which reflects only
Medicare fee-for-service patients (typically 65+). This does not represent total practice volume.
Industry payments span multiple years and payment types; disclosure alone establishes neither wrongdoing nor legality.
Rheumatology includes multiple subspecialties with different practice patterns.
Learn more →
Showing top 50 of 114 providers, ranked by Medicare service volume. Search by city to narrow results.
Rheumatology Providers — GA
NPPES · Open Payments · Medicare| Provider | City | Medicare Volume | Beneficiaries* | Top Procedure | Industry Payments | Payment Type | Coverage |
|---|---|---|---|---|---|---|---|
| CHAFIN, WILLIAM M.D. | Gainesville | 438,216 | — | Certolizumab injection (Cimzia) | $18,070 (2018-2024) | — | Very High |
| STEPHENS, DEAN M.D. | Savannah | 210,692 | — | Golimumab infusion (Simponi Aria) | $22,634 (2018-2024) | — | Very High |
| FLICKINGER, BRENT MD | Gainesville | 193,018 | — | Tocilizumab injection (Actemra) | $19,448 (2018-2024) | — | Very High |
| BOGNAR, MARTA M.D. | Gainesville | 192,155 | — | Certolizumab injection (Cimzia) | $21,516 (2018-2024) | — | Very High |
| BOURNIGAL, ERICK MD | Brunswick | 186,034 | — | Tocilizumab injection (Actemra) | $19,698 (2018-2024) | — | Very High |
| DEGENHARDT, CHARLES M.D. | Savannah | 182,902 | — | Golimumab infusion (Simponi Aria) | $12,154 (2018-2024) | — | Very High |
| TIDMORE, WILLIAM M.D. | Valdosta | 170,053 | — | Tocilizumab injection (Actemra) | $2,514 (2018-2024) | — | Very High |
| SUTEJ, PAUL MD | Atlanta | 166,496 | — | Golimumab infusion (Simponi Aria) | $236,409 (2018-2024) | — | Very High |
| AGHA, AMIR MD | Decatur | 137,907 | — | Golimumab infusion (Simponi Aria) | $58,246 (2018-2024) | — | Very High |
| MANGRU, JAGINDRA MD | Cumming | 120,940 | — | Certolizumab injection (Cimzia) | $45,373 (2018-2024) | — | Very High |
| LOVELL, TRACY M.D. | Gainesville | 110,742 | — | Tocilizumab injection (Actemra) | $412 (2018-2023) | — | Very High |
| PATEL, JATIN MD | Roswell | 79,130 | — | Certolizumab injection (Cimzia) | $5,237 (2018-2024) | — | Very High |
| GALEA, CHARLES M.D. | Waycross | 70,057 | — | Golimumab infusion (Simponi Aria) | $18,258 (2018-2024) | — | Very High |
| PELLER, JEFFREY MD | Rome | 68,620 | — | Romosozumab injection (Evenity) for osteoporosis | $3,806 (2018-2024) | — | Very High |
| SINGH, RATTANDEEP MD | Atlanta | 66,408 | — | Certolizumab injection (Cimzia) | $16,872 (2018-2024) | — | Very High |
| BHAT, ANNAPURNA MD | Stockbridge | 44,911 | — | Certolizumab injection (Cimzia) | $3,158 (2018-2024) | — | Very High |
| KHASNIS, ATUL M.D. | Tyrone | 41,459 | — | Certolizumab injection (Cimzia) | $1,931 (2018-2024) | — | Very High |
| JONNALA, GEETHA M.D | Snellville | 41,106 | — | Golimumab infusion (Simponi Aria) | $17,771 (2018-2024) | — | Very High |
| WILSON, WILLIAM MD | Atlanta | 39,721 | — | Golimumab infusion (Simponi Aria) | $353,926 (2018-2024) | — | Very High |
| SOHAIL, HUMA MD | Gainesville | 39,340 | — | Certolizumab injection (Cimzia) | $12,557 (2018-2024) | — | Very High |
| SETIA, NANDINI MD | Atlanta | 33,708 | — | Golimumab infusion (Simponi Aria) | $7,316 (2020-2024) | — | Very High |
| CARBONE, GUSTAVO M.D. | Savannah | 25,247 | — | Golimumab infusion (Simponi Aria) | $10,869 (2018-2024) | — | Very High |
| FIELD, RICHARD MD | Augusta | 25,226 | — | Golimumab infusion (Simponi Aria) | $18,395 (2018-2024) | — | Very High |
| BHAWAL, JAVERIA MD | Marietta | 24,855 | — | Romosozumab injection (Evenity) for osteoporosis | $11,038 (2018-2024) | — | Very High |
| CROWLEY, NANNETTE M.D. | Macon | 24,547 | — | Golimumab infusion (Simponi Aria) | $24,583 (2018-2024) | — | Very High |
| KOHLI, RITESH M.D. | Marietta | 20,555 | — | Golimumab infusion (Simponi Aria) | $14,911 (2018-2024) | — | Very High |
| MATHEW, RYAN M.D. | Kennesaw | 19,813 | — | Certolizumab injection (Cimzia) | $9,304 (2018-2024) | — | Very High |
| KIM, TAIK M.D. | Roswell | 19,669 | — | Romosozumab injection (Evenity) for osteoporosis | $11,507 (2018-2024) | — | Very High |
| LIEBERMAN, JEFREY MD | Decatur | 19,420 | — | Abatacept infusion (Orencia) | $280,874 (2018-2024) | — | Very High |
| MASSEOUD, DANIA M.D. | Atlanta | 14,259 | — | Golimumab infusion (Simponi Aria) | $15,840 (2018-2024) | — | Very High |
| EJIEKE, NONYELUM MD | Cartersville | 12,435 | — | Denosumab injection (Prolia/Xgeva) | $1,536 (2018-2024) | — | Very High |
| JAWAID, MEHRIN DO | Marietta | 12,185 | — | Romosozumab injection (Evenity) for osteoporosis | $6,018 (2020-2024) | — | Very High |
| SAMAKUR, MADHURIKA D.O. | Lawrenceville | 8,212 | — | Golimumab infusion (Simponi Aria) | $21,859 (2018-2024) | — | Very High |
| THAKKAR, AMITA M.D. | Cumming | 7,614 | — | Denosumab injection (Prolia/Xgeva) | $9,386 (2018-2024) | — | Very High |
| SACHDEVA, ALOK M.D. | Gainesville | 7,332 | — | Denosumab injection (Prolia/Xgeva) | $9,598 (2018-2024) | — | Very High |
| TAMESIS, ERIC MD | Augusta | 7,315 | — | Denosumab injection (Prolia/Xgeva) | $8,531 (2018-2024) | — | Very High |
| MOSSELL, JAMES D.O. | Tifton | 6,311 | — | Denosumab injection (Prolia/Xgeva) | $1,655,910 (2018-2024) | — | Very High |
| WOLFF, ZACHARY MD | Augusta | 5,897 | — | Infliximab infusion (Remicade) | $6,821 (2018-2024) | — | Very High |
| BHAVSAR, TEJ MD | Cumming | 5,577 | — | Office visit, established patient (30-39 min) | $16,274 (2018-2024) | — | Very High |
| DOLD, SYLVIA DO | Gainesville | 5,167 | — | Denosumab injection (Prolia/Xgeva) | $2,973 (2018-2024) | — | Very High |
| KAUL, MALA MD | Atlanta | 5,158 | — | Denosumab injection (Prolia/Xgeva) | $8,780 (2018-2024) | — | Very High |
| VIVAS, JAIME M.D. | Columbus | 4,763 | — | Infliximab-axxq biosimilar injection, 10 mg | $345 (2018-2024) | — | Very High |
| REDDY, SISIRA | Atlanta | 4,741 | — | Denosumab injection (Prolia/Xgeva) | $4,629 (2018-2024) | — | Very High |
| GUPTA, MANMOHAN M.D. | Macon | 4,069 | — | Urinalysis, manual | $8,048 (2018-2024) | — | Very High |
| QUERUBIN, ROEL M.D. | Marietta | 3,633 | — | Denosumab injection (Prolia/Xgeva) | $23,817 (2018-2024) | — | Very High |
| GOTTLIEB, ALAN MD | Jonesboro | 3,624 | — | Blood draw (venipuncture) | $821 (2018-2024) | — | Very High |
| TILIAKOS, ALEXANDRA MD | Lawrenceville | 3,531 | — | Denosumab injection (Prolia/Xgeva) | $4,996 (2018-2024) | — | Very High |
| JAFRI, KASHIF M.D. | Atlanta | 3,076 | — | Denosumab injection (Prolia/Xgeva) | $8,503 (2018-2024) | — | Very High |
| SHARMA, PALLAVI M.D. | Stockbridge | 3,049 | — | Infliximab infusion (Remicade) | $2,146 (2018-2024) | — | Very High |
| GRANT, DANIEL MD | Rome | 2,864 | — | Blood draw (venipuncture) | $1,944 (2020-2024) | — | Very High |
Note: Rheumatology encompasses multiple subspecialties with different practice patterns.
Differences in payment amounts and procedure volumes may reflect subspecialty focus
rather than practice quality. Consider viewing individual profiles for full context.